timothy sykes logo
ONCO Stock Pops As Realbotix AI Robotics Deal Gains Backing Thumbnail
G Google News

ONCO Stock Pops As Realbotix AI Robotics Deal Gains Backing

TIM SYKES•UPDATED SEP. 25, 2026, 7:47 AM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

Onconetix Inc. stocks have been trading up by 20.75 percent after pivotal oncology trial success fueled bullish investor sentiment.

Key Takeaways

  • Onconetix is proceeding with an all‑stock acquisition of Realbotix LLC, expected to close in 2H 2026 pending shareholder and regulatory approvals, after which the combined company will trade on Nasdaq.
  • The company is providing up to $5M in non‑interest‑bearing bridge financing to Realbotix, with an initial $2.5M draw to fund growth and working capital ahead of closing.
  • Realbotix has launched a pilot with a major European telecom operator using its AI humanoid robots as presenters, hosts, and brand ambassadors at live events.
  • SRX Global has made a strategic investment in Onconetix ahead of the Realbotix acquisition, viewing the Vinci AI Vision system as an undervalued AI/robotics platform with defense and surveillance potential.
  • SRX Global also sees Realbotix’s broader AI‑powered humanoid robotics technology as having multiple defense applications, adding a higher‑stakes angle to the ONCO story.

Candlestick Chart

Live Update At 07:47:17 EDT: On Friday, September 25, 2026 Onconetix Inc. stock [NASDAQ: ONCO] is trending up by 20.75%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

ONCO is trading like a classic speculative story stock. Over the past few weeks, Onconetix has climbed from the $0.60s into the low $0.90s, with several sessions pushing as high as $1.05. That’s a strong percentage move off the late‑August base near $0.60, and it tells traders that momentum money is quietly rotating into ONCO ahead of the Realbotix catalyst.

Intraday, the 5‑minute chart shows ONCO holding above $1.00 for extended stretches, with repeated pushes into the $1.10–$1.15 area. That intraday support just over a buck suggests dip buyers are active and shorts are cautious about pressing too hard into news risk.

More Breaking News

Fundamentally, Onconetix is still in heavy build‑out mode. Revenue is tiny at about $0.82M, yet gross margin is high at 87.6%, which fits an early‑stage, high‑markup tech or health platform. Losses are steep, with negative returns on equity and assets, and EBITDA deeply in the red. ONCO is plugging that gap with equity funding — roughly $4.27M of recent stock issuance boosted cash to about $5.94M and left the balance sheet with low debt and a current ratio around 2.2. For traders, this is a dilution‑driven, story‑first name where price action and catalysts matter more than near‑term earnings.

Why Traders Are Watching ONCO’s Realbotix Deal

Onconetix is trying to reinvent itself around AI‑powered humanoid robotics, and that pivot is exactly why traders are swarming ONCO. The centerpiece is the planned all‑stock acquisition of Realbotix, a company building humanoid robots and the Vinci AI Vision system, with clear angles in defense, surveillance, and live event engagement.

SRX Global stepping in as a strategic backer is a major credibility signal. SRX is treating the Realbotix platform as undervalued and strategically important, especially on the defense side. When an institutional‑style player labels a niche AI/robotics platform “undervalued” and puts money behind it, short‑term traders pay attention. It often means deeper pockets are now watching the same tape.

ONCO’s bridge financing — up to $5M, starting with $2.5M — shows real commitment to closing the Realbotix deal. The note carries no interest if the transaction completes and simply reduces the cash needed at closing. If the deal falls apart, that same note flips to a 12% interest‑bearing obligation, which turns into a clear overhang. So ONCO traders are essentially betting not just on AI hype, but on management’s ability to execute and push the merger across the finish line.

Meanwhile, Realbotix is not just a concept slide deck. Its AI humanoid robots are already in a pilot with a major European telecom operator, acting as presenters and brand ambassadors at live events. That’s early, but it is real‑world validation that these robots can generate commercial demand outside of defense. For ONCO, any update that this pilot expands, renews, or spawns new corporate clients becomes a potential volume spike and chart catalyst.

Conclusion

ONCO now sits at the crossroads of two hot themes — AI and defense — and that is reshaping how traders frame the stock. Onconetix is still a small, loss‑making name with heavy negative margins, but it has a clean balance sheet, growing cash, and a high‑story acquisition in Realbotix that the market is starting to price in. The planned Nasdaq listing of the combined company in 2H 2026 sets a clear timeline that short‑term traders can trade around.

The all‑stock structure of the Realbotix deal brings dilution, yet it also preserves cash at a time when ONCO is funding growth with equity. The bridge loan adds execution risk, but its design — zero interest if the deal closes — aligns Onconetix tightly with Realbotix’s success. SRX Global’s entry on the cap table signals that more sophisticated money wants exposure to Vinci AI Vision and its defense and surveillance potential.

For active traders, ONCO is not about stable cash flows; it is about timing the narrative. As Tim Sykes likes to say, “The market rewards preparation, not predictions.” As millionaire penny stock trader and teacher Tim Sykes, says, “The goal is not to win every trade but to protect your capital and keep moving forward.”. ONCO rewards traders who track every Realbotix headline, watch how the stock behaves around $1.00, and stay ready to strike when volume surges and the story hits the front page again. This is educational research, not a buy or sell call — your edge comes from doing the homework and managing risk like a pro.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”